These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36557043)

  • 1. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing.
    Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Analysis of SARS-CoV-2 Lineages in Armenia.
    Avetyan D; Hakobyan S; Nikoghosyan M; Ghukasyan L; Khachatryan G; Sirunyan T; Muradyan N; Zakharyan R; Chavushyan A; Hayrapetyan V; Hovhannisyan A; Mohamed Bakhash SA; Jerome KR; Roychoudhury P; Greninger AL; Niazyan L; Davidyants M; Melik-Andreasyan G; Sargsyan S; Nersisyan L; Arakelyan A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term monitoring of SARS-CoV-2 variants in wastewater using a coordinated workflow of droplet digital PCR and nanopore sequencing.
    Vigil K; D'Souza N; Bazner J; Cedraz FM; Fisch S; Rose JB; Aw TG
    Water Res; 2024 May; 254():121338. PubMed ID: 38430753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India.
    Nagaraja M; Sireesha K; Srikar A; Sudheer Kumar K; Mohan A; Vengamma B; Tirumala C; Verma A; Kalawat U
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study.
    Novkovic M; Banovic Djeri B; Ristivojevic B; Knezevic A; Jankovic M; Tanasic V; Radojicic V; Keckarevic D; Vidanovic D; Tesovic B; Skakic A; Tolinacki M; Moric I; Djordjevic V
    Front Microbiol; 2024; 15():1332276. PubMed ID: 38476954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2.
    Carbo EC; Mourik K; Boers SA; Munnink BO; Nieuwenhuijse D; Jonges M; Welkers MRA; Matamoros S; van Harinxma Thoe Slooten J; Kraakman MEM; Karelioti E; van der Meer D; Veldkamp KE; Kroes ACM; Sidorov I; de Vries JJC
    Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):701-713. PubMed ID: 37017810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing.
    Mannsverk S; Bergholm J; Palanisamy N; Ellström P; Kaden R; Lindh J; Lennerstrand J
    Virol J; 2022 Oct; 19(1):164. PubMed ID: 36258215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants.
    Wagner GE; Totaro MG; Volland A; Lipp M; Saiger S; Lichtenegger S; Forstner P; von Laer D; Oberdorfer G; Steinmetz I
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
    Päll T; Abroi A; Avi R; Niglas H; Shablinskaja A; Pauskar M; Jõgeda EL; Soeorg H; Kallas E; Lahesaare A; Truusalu K; Hoidmets D; Sadikova O; Ratnik K; Sepp H; Dotsenko L; Epštein J; Suija H; Kaarna K; Smit S; Milani L; Metspalu M; Oopkaup OE; Koppel I; Jaaniso E; Kuzmin I; Inno H; Raudvere U; Härma MA; Naaber P; Reisberg T; Peterson H; Talas UG; Lutsar I; Huik K
    PLoS One; 2024; 19(5):e0303176. PubMed ID: 38728305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing.
    Kia P; Katagirya E; Kakembo FE; Adera DA; Nsubuga ML; Yiga F; Aloyo SM; Aujat BR; Anguyo DF; Katabazi FA; Kigozi E; Joloba ML; Kateete DP
    Sci Rep; 2023 Nov; 13(1):20507. PubMed ID: 37993530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing.
    Wang Y; Chen D; Zhu C; Zhao Z; Gao S; Gou J; Guo Y; Kong X
    Front Immunol; 2022; 13():814806. PubMed ID: 35444655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and genetic characterization of SARS-CoV-2 in Kuwait: A descriptive study.
    Madi N; Safar HA; Mustafa AS; Chehadeh W; Asadzadeh M; Sadeq M; Alawadhi E; Al-Muhaini A; Benthani FA
    Front Microbiol; 2022; 13():858770. PubMed ID: 36090111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing.
    Buenestado-Serrano S; Herranz M; Otero-Sobrino Á; Molero-Salinas A; Rodríguez-Grande C; Sanz-Pérez A; Durán Galván MJ; Catalán P; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    Int J Med Microbiol; 2024 Mar; 314():151599. PubMed ID: 38290400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
    Azami NAM; Perera D; Thayan R; AbuBakar S; Sam IC; Salleh MZ; Isa MNM; Ab Mutalib NS; Aik WK; Suppiah J; Tan KK; Chan YF; Teh LK; Azzam G; Rasheed ZBM; Chan JCJ; Kamel KA; Tan JY; Khalilur Rahman O; Lim WF; Johari NA; Ishak M; Yunos RIM; Anasir MI; Wong JE; Fu JYL; Noorizhab MNF; Sapian IS; Mokhtar MFM; Md Shahri NAA; Ghafar K; Yusuf SNHM; Noor YM; Jamal R;
    Int J Infect Dis; 2022 Dec; 125():216-226. PubMed ID: 36336246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of SARS-CoV-2 Genetic Variants in the Polish Armed Forces Using Whole Genome Sequencing Analysis.
    Skuza K; Rutyna P; Krzowski L; Rabalski L; Lepionka T
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing.
    Trémeaux P; Latour J; Ranger N; Ferrer V; Harter A; Carcenac R; Boyer P; Demmou S; Nicot F; Raymond S; Izopet J
    Microbiol Spectr; 2023 Aug; 11(4):e0049323. PubMed ID: 37260377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis.
    Colson P; Delerce J; Marion-Paris E; Lagier JC; Levasseur A; Fournier PE; La Scola B; Raoult D
    Infect Genet Evol; 2022 Nov; 105():105360. PubMed ID: 36070806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.